BACKGROUND: Biopsy specimens are often obtained in the evaluation of hematogenous vertebral osteomyelitis. The effect of prebiopsy antibiotic exposure on pathogen recovery is unknown. METHODS: We conducted a retrospective cohort study of adult inpatients with hematogenous vertebral osteomyelitis at a tertiary care hospital from 1 January 2003 through 31 July 2007. Antibiotic exposure within 14 days before biopsy was evaluated. RESULTS: Of 150 patients with hematogenous vertebral osteomyelitis, 92 (61%) underwent a biopsy (60 [65%] needle and 32 [35%] open biopsies). The median time from admission to biopsy was 3 days (range, 0-69 days). Patients who underwent biopsy were more likely to have weakness (53 [58%] biopsy vs 15 [26%] no biopsy; P<.001) and sensory loss (27 [29%] vs 6 [10%]; P=.006), but were less likely to have a positive blood culture result (28 [30%] vs 30 [52%]; P=.01). Pathogens were recovered in 61 patients (66%). Open biopsy had a higher yield than needle biopsy (29 [91%] of 32 vs 32 [53%] of 60; P<.001). Sixty patients (65%) who had biopsies performed received antibiotics ≤14 days before the procedure (median duration, 4 days; range, 1-37 days). Open biopsy predicted positive biopsy culture results (adjusted odds ratio, 8.4; 95% confidence interval, 2.2-31.8), but there was no association of prebiopsy antibiotics with culture results (adjusted odds ratio, 2.3; 95% confidence interval, 0.8-6.2). CONCLUSIONS: A pathogen was recovered from 61 (66%) of 92 patients who had biopsies performed in this cohort of hematogenous vertebral osteomyelitis. Open biopsies had a higher microbiological yield than did needle biopsies. Antibiotic exposure before biopsy did not negatively impact pathogen recovery and should not be the sole reason for foregoing biopsies.
BACKGROUND: Biopsy specimens are often obtained in the evaluation of hematogenous vertebral osteomyelitis. The effect of prebiopsy antibiotic exposure on pathogen recovery is unknown. METHODS: We conducted a retrospective cohort study of adult inpatients with hematogenous vertebral osteomyelitis at a tertiary care hospital from 1 January 2003 through 31 July 2007. Antibiotic exposure within 14 days before biopsy was evaluated. RESULTS: Of 150 patients with hematogenous vertebral osteomyelitis, 92 (61%) underwent a biopsy (60 [65%] needle and 32 [35%] open biopsies). The median time from admission to biopsy was 3 days (range, 0-69 days). Patients who underwent biopsy were more likely to have weakness (53 [58%] biopsy vs 15 [26%] no biopsy; P<.001) and sensory loss (27 [29%] vs 6 [10%]; P=.006), but were less likely to have a positive blood culture result (28 [30%] vs 30 [52%]; P=.01). Pathogens were recovered in 61 patients (66%). Open biopsy had a higher yield than needle biopsy (29 [91%] of 32 vs 32 [53%] of 60; P<.001). Sixty patients (65%) who had biopsies performed received antibiotics ≤14 days before the procedure (median duration, 4 days; range, 1-37 days). Open biopsy predicted positive biopsy culture results (adjusted odds ratio, 8.4; 95% confidence interval, 2.2-31.8), but there was no association of prebiopsy antibiotics with culture results (adjusted odds ratio, 2.3; 95% confidence interval, 0.8-6.2). CONCLUSIONS: A pathogen was recovered from 61 (66%) of 92 patients who had biopsies performed in this cohort of hematogenous vertebral osteomyelitis. Open biopsies had a higher microbiological yield than did needle biopsies. Antibiotic exposure before biopsy did not negatively impact pathogen recovery and should not be the sole reason for foregoing biopsies.
Authors: J D Colmenero; M E Jiménez-Mejías; F J Sánchez-Lora; J M Reguera; J Palomino-Nicás; F Martos; J García de las Heras; J Pachón Journal: Ann Rheum Dis Date: 1997-12 Impact factor: 19.103
Authors: Frank L Acosta; Cynthia T Chin; Alfredo Quiñones-Hinojosa; Christopher P Ames; Philip R Weinstein; Dean Chou Journal: Neurosurg Focus Date: 2004-12-15 Impact factor: 4.047
Authors: Enrique Marco de Lucas; Andrés González Mandly; Agustín Gutiérrez; Raúl Pellón; Laura Martín-Cuesta; Javier Izquierdo; Elena Sánchez; Eva Ruiz; Fernando Quintana Journal: Clin Rheumatol Date: 2008-11-29 Impact factor: 2.980
Authors: M Loibl; L Stoyanov; C Doenitz; A Brawanski; P Wiggermann; W Krutsch; M Nerlich; M Oszwald; C Neumann; B Salzberger; F Hanses Journal: Infection Date: 2014-01-21 Impact factor: 3.553
Authors: G Gras; R Buzele; J J Parienti; F Debiais; A Dinh; M Dupon; F Roblot; D Mulleman; C Marcelli; J Michon; L Bernard Journal: Eur J Clin Microbiol Infect Dis Date: 2013-09-21 Impact factor: 3.267
Authors: David Knipp; F Joseph Simeone; Sandra B Nelson; Ambrose J Huang; Connie Y Chang Journal: Skeletal Radiol Date: 2017-11-15 Impact factor: 2.199
Authors: Jason F Talbott; Vinil N Shah; Alina Uzelac; Jared Narvid; Rebecca A Dumont; Cynthia T Chin; David M Wilson Journal: Semin Ultrasound CT MR Date: 2018-09-26 Impact factor: 1.875
Authors: Elena Lazzeri; Alessandro Bozzao; Maria Adriana Cataldo; Nicola Petrosillo; Luigi Manfrè; Andrej Trampuz; Alberto Signore; Mario Muto Journal: Eur J Nucl Med Mol Imaging Date: 2019-08-09 Impact factor: 9.236